Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Hypofractionated Stereotactic Body Radiation Therapy (SBRT) [Phase 2]
Phase 2 trial evaluating hypofractionated stereotactic body radiation therapy for prostate cancer has completed; results were posted in June…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: EMBRACE1: Prostate Biorepository
The EMBRACE1 Prostate Biorepository trial sponsored by Caris Science, Inc. has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic interaction study evaluating whether fluconazole and atorvastatin alter the exposure of TAK-385 in healthy subjects;…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery [NA]
A completed clinical trial evaluating the effects of green tea, black tea, or water in patients undergoing prostate cancer surgery; results …
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy
A research trial is evaluating deformable registration of multi-parametric MRI to intra-operative transrectal ultrasound to aid prostate bra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 study evaluating the impact of Orteronel on QT/QTc interval in patients with metastatic castration-resistant prostate cancer; result…
-
CLINICAL_TRIALS research · 2016-05-30Clinical Trial Update: Assessment of Bone Loss in Men Receiving Treatment for Prostate Cancer
A clinical trial update evaluating bone loss in men receiving treatment for prostate cancer.
-
FDA approval · 2016-05-27FDA Approved: AXUMIN — Original Application (Blue Earth Diagnostics)
The FDA approves AXUMIN (fluciclovine F-18) in an original application for PET imaging to detect recurrent prostate cancer, with Blue Earth …
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy [Phase 3]
Phase 3 trial evaluating risedronate to prevent skeletal-related events in patients with metastatic prostate cancer starting hormonal therap…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer [Phase 1]
Phase 1 trial evaluating the combination of everolimus, bicalutamide, and leuprolide acetate with radiation therapy for high-risk locally ad…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Effects of ASA on Prostate Tissue [NA]
A completed clinical trial studied the effects of aspirin on prostate tissue in men with prostate cancer; results are not provided in the ex…
-
CLINICAL_TRIALS withdrawal · 2016-05-25Clinical Trial Update: Imaging of Residual Tumor During Prostatectomy
The clinical trial 'Imaging of Residual Tumor During Prostatectomy' (NCT01173146) sponsored by Spectros Corporation has been withdrawn and i…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer [Phase 2]
This Phase 2 trial compares enzalutamide to bicalutamide in men with prostate cancer to assess comparative safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer [Phase 2]
Phase 2 trial investigating abiraterone acetate with prednisolone in advanced prostate cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating sipuleucel-T with or without tasquinimod in metastatic hormone-resistant prostate cancer has completed, with result…
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization System
This clinical trial update discusses reducing planning target volume margins for prostate cancer treatment using the Calypso 4D localization…
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the Prostate
This clinical trial update describes a study comparing external immobilization to limited immobilization using a novel real-time localizatio…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery [Phase 4]
Phase 4 clinical trial evaluating Guardix-solution to prevent postoperative intestinal adhesion and obstruction after laparoscopic pelvic ca…
-
CLINICAL_TRIALS withdrawal · 2016-05-13Clinical Trial Update: Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries
A clinical trial assessing epidemiology, clinical features and genetics of prostate cancer in Arab countries has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Stereotactic Volumetric Radiotherapy in Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating stereotactic volumetric radiotherapy for prostate cancer. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy [Phase 2]
Phase 2 trial evaluating abiraterone with different steroid regimens to prevent mineralocorticoid excess side effects in prostate cancer bef…
-
FDA approval · 2016-05-10FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for bicalutamide, authorizing changes to the product's labeling.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer [Phase 1]
This Phase 1 study of lenalidomide in combination with docetaxel for androgen-independent prostate cancer has completed, evaluating safety, …
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer [NA]
Pilot study results for a combination of parenteral testosterone and oral etoposide in men with castration-resistant prostate cancer; the tr…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Efficacy Study Evaluating Chemotherapy in Prostate Cancer [Phase 3]
A Phase 3 clinical trial evaluating chemotherapy for prostate cancer. The provided snippet does not disclose the trial status or results.